Search This Blog

Wednesday, May 13, 2026

STAAR beats, returns to profitability

 

STAAR Surgical beats Q1 expectations with adjusted EPS $0.38 on revenue of $93.5 million

  • Analyst expectations were $0.13 per share adjusted EPS, compared with reported $0.38 per share.
  • Q1 2026 net sales were $93.5 million and EPS was $0.10.
  • The company returned to profitability in Q1 2026 while topping consensus expectations.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.